Acumen Pharmaceuticals Inc.
ABOS | NASDAQ
$2.62
+$0.03 (+1.16%)
Sep 22, 2026, 1:47 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 329K | 1.06M | 1.21M |
Cost of Revenue | 46K | 46K | n/a | 44K | 44K | 44K | 44K | 39K | 512K | 9.65M | 18.36M | 29.07M | 36.9M | 35.09M | 32.36M | 27.29M | 20.78M | 15.71M | 9.73M | 5.08M | 6.27M | 5.95M |
Gross Profit | -46K | -46K | n/a | -44K | -44K | -44K | -44K | -39K | -512K | -9.65M | -18.36M | -29.07M | -36.9M | -35.09M | -32.36M | -27.29M | -20.78M | -15.71M | -9.73M | -4.75M | -5.22M | -4.74M |
Operating Income | -105.42M | -114.61M | -123.83M | -138.23M | -143.98M | -126.61M | -114.02M | -92.91M | -76.68M | -65.78M | -61.14M | -56.9M | -52.23M | -49.17M | -45.24M | -39.4M | -31.97M | -25M | -19.58M | -12.51M | -11.07M | -9.66M |
Interest Income | 5.14M | 6.04M | 7.45M | 9.12M | 10.98M | 12.78M | 14.32M | 15.28M | 14.9M | 12.96M | 10.79M | 8.23M | 5.77M | 4.15M | 2.39M | 1.04M | 412K | 156K | 84K | 45K | 8K | 4K |
Pretax Income | -105.04M | -113.28M | -121.34M | -133.35M | -136.67M | -116.25M | -102.33M | -81.67M | -64.86M | -55.94M | -52.37M | -48.74M | -46.49M | -45.03M | -42.86M | -38.34M | -31.53M | -82.74M | -100.61M | -93.01M | -91.6M | -32.28M |
Net Income | -105.04M | -113.28M | -121.34M | -133.35M | -136.67M | -116.25M | -102.33M | -81.67M | -64.86M | -55.94M | -52.37M | -48.74M | -46.49M | -45.03M | -42.86M | -38.34M | -31.53M | -82.74M | -100.61M | -93.01M | -91.6M | -32.28M |
Selling & General & Admin | 18.58M | 18.46M | 18.95M | 19.3M | 19.78M | 20M | 20.22M | 20.35M | 20.19M | 19.68M | 18.78M | 17.13M | 15.33M | 14.08M | 12.88M | 12.12M | 11.19M | 9.29M | 7.28M | 5.18M | 3.27M | 2.34M |
Research & Development | 86.79M | 96.1M | 104.89M | 118.93M | 124.21M | 106.62M | 93.8M | 72.52M | 56.45M | 46.05M | 42.32M | 39.77M | 36.9M | 35.09M | 32.36M | 27.29M | 20.78M | 15.71M | 12.31M | 7.66M | 8.85M | 8.53M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -473K | -9.61M | -18.32M | -29.07M | -36.9M | -35.09M | -32.36M | -27.29M | -20.78M | -15.71M | -9.73M | -5.08M | -6.27M | -5.95M |
Operating Expenses | 105.37M | 114.57M | 123.83M | 138.19M | 143.94M | 126.57M | 113.97M | 92.87M | 76.17M | 56.13M | 42.78M | 27.84M | 15.33M | 14.08M | 12.88M | 12.12M | 11.19M | 9.29M | 9.86M | 7.76M | 5.85M | 4.92M |
Interest Expense | 4.32M | 4.27M | 4.22M | 4.17M | 4.13M | 4.09M | 4.07M | 3.61M | 2.59M | 1.58M | 581K | n/a | n/a | n/a | n/a | n/a | 23K | 23K | 23K | 23K | n/a | n/a |
Selling & Marketing Expenses | -46K | -46K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 105.42M | 114.61M | 123.83M | 138.23M | 143.98M | 126.61M | 114.02M | 92.91M | 76.68M | 65.78M | 61.14M | 56.9M | 52.23M | 49.17M | 45.24M | 39.4M | 31.97M | 25M | 19.58M | 12.84M | 12.12M | 10.87M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 72.25M | 63.22M | 60.56M | 60.57M | 60.57M | 60.53M | 60.01M | 60.08M | 60.08M | 59.81M | 57.91M | 54.23M | 41.03M | 41.03M | 40.86M | 40.5M | 40.5M | 40.47M | 38.27M | 38.27M | 38.65M | 36.99M |
Shares Outstanding (Diluted) | 72.25M | 63.22M | 60.56M | 60.57M | 60.57M | 60.53M | 60.01M | 60.08M | 60.08M | 59.81M | 58.01M | 54.23M | 41.03M | 41.03M | 40.86M | 40.5M | 40.5M | 40.47M | 38.27M | 38.27M | 38.65M | 36.99M |
EPS (Basic) | -1.64 | -1.87 | -2.02 | -2.22 | -2.28 | -1.94 | -1.71 | -1.37 | -1.11 | -1.05 | -1.03 | -1.09 | -1.10 | -1.06 | -1.05 | -0.93 | -0.78 | -2.13 | -2.64 | -2.45 | -2.43 | -0.91 |
EPS (Diluted) | -1.64 | -1.87 | -2.02 | -2.22 | -2.28 | -1.94 | -1.71 | -1.37 | -1.11 | -1.05 | -1.03 | -1.09 | -1.10 | -1.06 | -1.05 | -0.93 | -0.78 | -2.13 | -2.64 | -2.45 | -2.43 | -0.91 |
EBITDA | -100.4M | -108.82M | -116.93M | -128.99M | -132.35M | -111.98M | -98.08M | -77.89M | -62.14M | -54.25M | -51.71M | -48.69M | -46.44M | -44.99M | -42.82M | -38.32M | -31.49M | -79.27M | -73.93M | -65.59M | -61.71M | -3.79M |
EBIT | -100.73M | -109.01M | -117.11M | -129.18M | -132.53M | -112.16M | -98.26M | -78.06M | -62.28M | -54.36M | -51.79M | -48.74M | -46.49M | -45.03M | -42.86M | -38.34M | -31.51M | -82.72M | -77.38M | -70.37M | -68.98M | -9.66M |
Depreciation & Amortization | 322K | 185K | 184K | 183K | 181K | 179K | 178K | 173K | 141K | 111K | 81K | 54K | 51K | 42K | 32K | 23K | 13.33K | 3.45M | 3.44M | 4.78M | 7.27M | 5.87M |
Add to Watchlist
Select watchlists to add or remove ABOS